NATURE’S SUNSHINE PRODUCTS, INC. Income Taxes Paid
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Income Taxes Paid of $6.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $3.68M, a 15.20% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $2.38M, a 26.67% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $4.85M, a 3.16% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $1.49M, a 9.16% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for fiscal 2025 was $12.55M, a 15.15% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for fiscal 2024 was $14.79M, a 59.63% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. income taxes paid, net for fiscal 2023 was $9.26M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.05M 10-Q · filed 2026-08-06 | $10.90M derived: sum of 3 quarters · filed 2026-08-06 | $12.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-07 | $7.22M derived: sum of 2 quarters · filed 2026-05-07 | $8.71M derived: sum of 3 quarters · filed 2026-05-07 | $13.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.34M derived: sum of 2 quarters · filed 2026-03-10 | $10.67M derived: sum of 3 quarters · filed 2026-08-06 | $12.55M 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.82M derived: sum of 2 quarters · filed 2026-08-06 | $7.70M 10-Q · filed 2025-11-06 | $12.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.21M 10-Q · filed 2026-08-06 | $11.22M derived: sum of 3 quarters · filed 2026-08-06 | $12.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.88M 10-Q · filed 2026-05-07 | $6.88M derived: sum of 2 quarters · filed 2026-05-07 | $8.52M derived: sum of 3 quarters · filed 2026-05-07 | $15.28M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.64M derived: sum of 2 quarters · filed 2026-03-10 | $13.40M derived: sum of 3 quarters · filed 2026-03-10 | $14.79M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.40M derived: sum of 2 quarters · filed 2025-11-06 | $9.78M 10-Q · filed 2025-11-06 | $11.59M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $6.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $8.14M 10-Q · filed 2025-07-31 | $9.95M derived: sum of 3 quarters · filed 2025-07-31 | $12.28M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-06 | $3.19M derived: sum of 2 quarters · filed 2025-05-06 | $5.52M derived: sum of 3 quarters · filed 2025-05-06 | $8.66M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $4.13M derived: sum of 2 quarters · filed 2025-03-11 | $7.27M derived: sum of 3 quarters · filed 2025-03-11 | $9.26M 10-K · filed 2025-03-11 |
| 2023-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $5.47M derived: sum of 2 quarters · filed 2024-11-07 | $7.46M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.13M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $1.99M 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | -$787.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.58M derived: sum of 2 quarters · filed 2023-11-07 | $3.39M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.17M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $1.81M 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.40M derived: sum of 2 quarters · filed 2022-11-03 | $4.43M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.58M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $2.03M 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.07M derived: sum of 2 quarters · filed 2021-11-04 | $3.29M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.14M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.22M 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.87M derived: sum of 2 quarters · filed 2020-11-09 | $5.21M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $549.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.90M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $3.35M 10-Q · filed 2020-05-11 | |||
| 2018-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.70M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $2.27M 10-Q · filed 2019-08-09 | |||
| 2017-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.87M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $2.42M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |